Niche Diagnostics IBL-America specializes in in-vitro diagnostic kits, antibodies and proteins across autoimmune, infectious disease, neuroscience and oncology, presenting cross-selling opportunities to researchers and medical device manufacturers seeking complementary reagents and assays.

Clinical Partnerships Collaborative potential with sister company KMI Diagnostics for integrated testing services and pre-clinical studies can be leveraged to offer end-to-end solutions to labs and device developers, strengthening value proposition.

Event Presence Active participation in Kidney Week 2025 signals access to nephrology and biomarker-focused buyers; replicate outreach at similar conferences to generate leads for autoimmune and brain research assay needs.

Recent Offerings Recent launches of Angiotensinogen ELISAs, Titin monoclonal antibodies and other ELISA kits indicate a track record of expanding assay portfolios; target labs and CROs needing specialized reagents and assay development support.

Low Revenue Growth With sub-$1M revenue and a small team, there is an opportunity to scale through channel partnerships, distributor networks, and targeted outbound campaigns highlighting the unique, hard-to-source reagents and custom assay capabilities.